Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.

@article{Qaqish2003AdefovirDA,
  title={Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.},
  author={Roula B. Qaqish and Keri A. Mattes and David J. Ritchie},
  journal={Clinical therapeutics},
  year={2003},
  volume={25 12},
  pages={
          3084-99
        }
}
BACKGROUND Hepatitis B virus (HBV) infection is a major problem worldwide and an important cause of chronic liver disease and cirrhosis. Currently available treatments include interferon alfa-2b, lamivudine, and adefovir dipivoxil. Adefovir dipivoxil is an acyclic nucleotide analogue that was developed in part to improve on the limitations of earlier therapies. OBJECTIVE This article is a review of available data on the clinical pharmacology, virology, efficacy, tolerability, and clinical use… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Hepatic complications of allogeneic hematopoietic cell transplantation.

VIEW 2 EXCERPTS
CITES BACKGROUND